Checklist: Medicare Advantage prior authorization clocks, notices and posted metrics

Twelve steps for Medicare Advantage organizations running prior authorization day to day: the 7-day and 72-hour clocks, when an extension or a refusal to expedite is allowed, what each notice must say, the yearly metrics, and the API due in 2027.

Three sections that set the pace

The CMS Interoperability and Prior Authorization final rule (CMS-0057-F) was published on February 8, 2024 (89 FR 8758) [5]. For Medicare Advantage it added section 422.122 and shortened the standard decision time in section 422.568 for items and services subject to prior authorization [1] [2]. CMS’s fact sheet says the operational provisions generally apply from January 1, 2026 and the API requirements generally from January 1, 2027, with exact dates varying by type of payer [6]. Section 422.570 governs when a request must be expedited, and section 422.572 sets the expedited clock [3] [4]. Section 422.122 excludes drugs, as section 422.119 defines them, and Part B drug requests keep their own, shorter clocks under sections 422.568 and 422.572.

Using the steps

Each step names the work, who usually owns it and the section behind it, from the current eCFR text. The owner under each step is a typical role, not one the rule names, unless the step says the rule names it. Where a step is our suggestion, it says so. Payers that also run Medicaid, CHIP or Exchange plans have parallel rules with their own dates that these steps do not cover. This page explains the rules; it is not legal advice.

Moraph’s teams help organizations with work like this. See our solutions.

The checklist

Tick the steps as you go. The ticks are kept in this browser only; nothing is sent to us.

  1. Utilization management operations

    Section 422.568(b)(1)(ii) gives 7 calendar days, beginning on or after January 1, 2026, for a standard decision on an item or service subject to section 422.122; (b)(1)(i) keeps 14 calendar days for other items and services; (b)(3) gives 72 hours for a Part B drug, with no extension [2].

  2. Utilization management operations

    Section 422.572(a)(1) and (2) [4]. The early alert is our suggestion.

  3. Medical director

    Section 422.570(c)(2)(i) and (ii). Section 422.570(c)(1) also requires an efficient and convenient means to submit oral or written requests, with every oral request documented in writing in the case file [3].

  4. Utilization management operations

    Section 422.570(d)(1) and (2). Paragraph (d)(1) points to the applicable standard timeframe in section 422.568, which is 7 calendar days for items and services subject to section 422.122. Paragraph (d)(2)(i), as it reads, says the letter explains that the plan “will process the request using the 14-day timeframe for standard determinations”; how to word the letter for 7-day requests is a question for counsel. The letter must also explain the right to file an expedited grievance and to resubmit with a physician’s support, and give instructions on the grievance process [3].

  5. Utilization management operations

    Section 422.568(b)(2) for standard requests and section 422.572(b) for expedited ones: the enrollee asks; more medical evidence from a noncontract provider may change a denial and the extension is in the enrollee’s interest; or extraordinary, exigent or other non-routine circumstances justify it in the enrollee’s interest [2] [4].

  6. Clinical intake

    Section 422.572(d) sets the 24 hours and keeps the plan responsible for meeting the timeframe either way [4].

  7. Utilization management operations with provider communications

    Section 422.122(a), beginning January 1, 2026, for denials made within the timeframes in sections 422.568(b)(1) and 422.572(a)(1), excluding drugs [1]. CMS’s fact sheet notes that the decision may go by portal, fax, email, mail or phone, and that the rule does not change existing notice requirements, which are often required in writing [6].

  8. Appeals and grievances lead

    Section 422.568(d) and (e) for the written notice; section 422.572(c) for written confirmation of an oral adverse expedited decision [2] [4].

  9. Compliance officer

    Section 422.568(f) says failure to give timely notice is itself an adverse organization determination that may be appealed [2]. The aging report is our suggestion.

  10. Provider network management

    Section 422.570(f) prohibits taking or threatening punitive action against such a physician [3].

  11. Medicare compliance with data analytics

    Section 422.122(c)(1) to (9), beginning in 2026, excluding drugs. The measures include the percentages of standard and expedited requests approved and denied, standard requests approved after appeal, extended requests that were approved, and the average and median decision times for standard and expedited requests [1]. The rule’s preamble says payers report the previous calendar year’s metrics by March 31 following any year they offered that type of plan [5].

  12. Interoperability program lead

    Section 422.122(b)(1) to (4) [1]. Section 422.122(b)(5) adds that the organization must still meet section 422.138 and subpart M; under section 422.137 an MA plan may use only utilization management policies, prior authorization included, that its utilization management committee has reviewed and approved [1] [7].

Spotted an error? Tell us and we will check it and correct the checklist where needed.

  • CMS
  • Medicare Advantage
  • prior authorization
  • 42 CFR 422.122
  • 42 CFR 422.568
  • 42 CFR 422.570
  • organization determinations
  • CMS-0057-F